Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Edward Williams, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Williams ME. Barriers to optimal ESKD management. Semin Dial. 2020 Nov; 33(6):437-439. PMID: 33210322.
    Citations:    Fields:    Translation:Humans
  2. Gaietto KJ, Williams ME. ATTENTION: Workforce shortages as a barrier to optimal dialysis. Semin Dial. 2020 Nov; 33(6):505-512. PMID: 33094515.
    Citations:    Fields:    Translation:Humans
  3. Williams ME. Said the glucose sensor to the insulin pump: can glycemic control be improved in hospitalized ESRD patients with diabetes mellitus? Kidney Int. 2019 09; 96(3):540-542. PMID: 31445578.
    Citations:    Fields:    Translation:Humans
  4. Williams ME, Mittman N, Ma L, Brennan JI, Mooney A, Johnson CD, Jani CM, Maddux FW, Lacson E. The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients. Hemodial Int. 2015 Oct; 19(4):562-71. PMID: 25965145.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  5. Williams ME. Hemoglobin a1c in the ESRD population: status report. Semin Dial. 2014 Nov-Dec; 27(6):559-62. PMID: 25040220.
    Citations: 1     Fields:    Translation:Humans
  6. Williams ME, Garg R. Glycemic management in ESRD and earlier stages of CKD. Am J Kidney Dis. 2014 Feb; 63(2 Suppl 2):S22-38. PMID: 24461727.
    Citations: 27     Fields:    Translation:Humans
  7. Williams ME, Garg R, Wang W, Lacson R, Maddux F, Lacson E. High Hemoglobin A1c levels and glycemic variability increase risk of severe hypoglycemia in diabetic hemodialysis patients. Hemodial Int. 2014 Apr; 18(2):423-32. PMID: 24274900.
    Citations: 5     Fields:    Translation:Humans
  8. Williams ME, Balogun RA. Principles of separation: indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol. 2014 Jan; 9(1):181-90. PMID: 24178973.
    Citations: 15     Fields:    Translation:Humans
  9. Shaz BH, Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Szczepiorkowski ZM, Williams ME, Wu Y, Linenberger ML. American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia. Clin Infect Dis. 2014 Jan; 58(2):302-3. PMID: 24092801.
    Citations: 2     Fields:    Translation:Humans
  10. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013 Jul; 28(3):145-284. PMID: 23868759.
    Citations: 130     Fields:    Translation:Humans
  11. Williams ME. Starting a new therapeutic apheresis service: medical directorship and other matters. J Clin Apher. 2013 Feb; 28(1):11-5. PMID: 23420590.
    Citations:    Fields:    Translation:Humans
  12. Williams ME. Diabetic kidney disease in elderly individuals. Med Clin North Am. 2013 Jan; 97(1):75-89. PMID: 23290731.
    Citations: 8     Fields:    Translation:Humans
  13. Williams ME. Diabetic chronic kidney disease: when the other shoe drops. Med Clin North Am. 2013 Jan; 97(1):xi-xii. PMID: 23290737.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  14. Garg R, Williams ME. Diabetes management in the kidney patient. Med Clin North Am. 2013 Jan; 97(1):135-56. PMID: 23290735.
    Citations: 9     Fields:    Translation:Humans
  15. Williams ME. Living longer: our challenges in geriatric ESRD. Introduction. Semin Dial. 2012 Nov-Dec; 25(6):601. PMID: 23173888.
    Citations:    Fields:    Translation:Humans
  16. Williams ME. Tough choices: dialysis, palliative care, or a third option for elderly ESRD. Semin Dial. 2012 Nov-Dec; 25(6):633-9. PMID: 23078127.
    Citations: 4     Fields:    Translation:Humans
  17. Williams ME, Sandeep J, Catic A. Aging and ESRD demographics: consequences for the practice of dialysis. Semin Dial. 2012 Nov-Dec; 25(6):617-22. PMID: 23067122.
    Citations: 6     Fields:    Translation:Humans
  18. Xu S, Williams ME, Pavlakis M, Breu AC. The UNOS 'preferential allocation' concept proposal for the allocation of deceased donor kidney transplants: implications for patients with diabetes. Nephrol Dial Transplant. 2012 Mar; 27(3):869-71. PMID: 22287657.
    Citations:    Fields:    Translation:Humans
  19. Williams ME. The goal of blood pressure control for prevention of early diabetic microvascular complications. Curr Diab Rep. 2011 Aug; 11(4):323-9. PMID: 21526351.
    Citations: 4     Fields:    Translation:Humans
  20. Sandhu GS, Khattak M, Rout P, Williams ME, Gautam S, Baird B, Goldfarb-Rumyantzev AS. Social Adaptability Index: application and outcomes in a dialysis population. Nephrol Dial Transplant. 2011 Aug; 26(8):2667-74. PMID: 21257678.
    Citations: 8     Fields:    Translation:Humans
  21. Williams ME, Lacson E, Wang W, Lazarus JM, Hakim R. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1595-601. PMID: 20671217.
    Citations: 31     Fields:    Translation:Humans
  22. Wright S, Klausner D, Baird B, Williams ME, Steinman T, Tang H, Ragasa R, Goldfarb-Rumyantzev AS. Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1828-35. PMID: 20634325.
    Citations: 71     Fields:    Translation:Humans
  23. Adler SG, Schwartz S, Williams ME, Arauz-Pacheco C, Bolton WK, Lee T, Li D, Neff TB, Urquilla PR, Sewell KL. Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol. 2010 Aug; 5(8):1420-8. PMID: 20522536.
    Citations: 78     Fields:    Translation:HumansCTClinical Trials
  24. Mahnensmith RL, Zorzanello M, Hsu YH, Williams ME. A quality improvement model for optimizing care of the diabetic end-stage renal disease patient. Semin Dial. 2010 Mar-Apr; 23(2):206-13. PMID: 20525109.
    Citations:    Fields:    Translation:Humans
  25. Williams ME. Improving outcomes for diabetic patients on dialysis-an introduction. Semin Dial. 2010 Mar-Apr; 23(2):127-8. PMID: 20525105.
    Citations:    Fields:    Translation:Humans
  26. Rosner M, Abdel-Rahman E, Williams ME. Geriatric nephrology: responding to a growing challenge. Clin J Am Soc Nephrol. 2010 May; 5(5):936-42. PMID: 20185600.
    Citations: 16     Fields:    Translation:Humans
  27. Williams ME. Diabetic CKD/ESRD 2010: a progress report? Semin Dial. 2010 Mar-Apr; 23(2):129-33. PMID: 20210917.
    Citations: 20     Fields:    Translation:Humans
  28. Williams ME. Management of diabetes in dialysis patients. Curr Diab Rep. 2009 Dec; 9(6):466-72. PMID: 19954693.
    Citations: 2     Fields:    Translation:Humans
  29. Williams ME. Chronic kidney disease/bone and mineral metabolism: the imperfect storm. Semin Nephrol. 2009 Mar; 29(2):97-104. PMID: 19371800.
    Citations: 8     Fields:    Translation:Humans
  30. Williams ME, Lacson E, Teng M, Hakim RM, Lazarus JM. Extremes of glycemic control (HbA1c) increase hospitalization risk in diabetic hemodialysis patients in the USA. Am J Nephrol. 2009; 29(1):54-61. PMID: 18689979.
    Citations: 9     Fields:    Translation:Humans
  31. Shan HY, Rana S, Epstein FH, Stillman IE, Karumanchi SA, Williams ME. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Am J Kidney Dis. 2008 Jun; 51(6):1029-32. PMID: 18455853.
    Citations: 7     Fields:    Translation:Humans
  32. Williams ME, Bolton WK, Khalifah RG, Degenhardt TP, Schotzinger RJ, McGill JB. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol. 2007; 27(6):605-14. PMID: 17823506.
    Citations: 80     Fields:    Translation:HumansCTClinical Trials
  33. Williams ME. The ESRD uninsured matter. Adv Chronic Kidney Dis. 2007 Jan; 14(1):67-74. PMID: 17200045.
    Citations: 4     Fields:    Translation:Humans
  34. Williams ME, Lacson E, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int. 2006 Oct; 70(8):1503-9. PMID: 16941022.
    Citations: 42     Fields:    Translation:Humans
  35. Williams ME. Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist's perspective. Clin J Am Soc Nephrol. 2006 Mar; 1(2):209-20. PMID: 17699209.
    Citations: 6     Fields:    Translation:Humans
  36. Williams ME. Internet organ solicitation, explained. Adv Chronic Kidney Dis. 2006 Jan; 13(1):70-5. PMID: 16412973.
    Citations: 1     Fields:    Translation:Humans
  37. Williams ME. New potential agents in treating diabetic kidney disease: the fourth act. Drugs. 2006; 66(18):2287-98. PMID: 17181372.
    Citations: 5     Fields:    Translation:HumansAnimals
  38. Williams ME, Tuttle KR. The next generation of diabetic nephropathy therapies: an update. Adv Chronic Kidney Dis. 2005 Apr; 12(2):212-22. PMID: 15822057.
    Citations: 10     Fields:    Translation:HumansAnimals
  39. Williams ME. Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol. 2005 Mar-Apr; 25(2):77-94. PMID: 15746541.
    Citations: 34     Fields:    Translation:Humans
  40. Williams ME, Kitsen J. The involuntarily discharged dialysis patient: conflict (of interest) with providers. Adv Chronic Kidney Dis. 2005 Jan; 12(1):107-12. PMID: 15719341.
    Citations: 1     Fields:    Translation:Humans
  41. Williams ME. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease. Curr Diab Rep. 2004 Dec; 4(6):441-6. PMID: 15539009.
    Citations: 7     Fields:    Translation:Humans
  42. Coburn JW, Maung HM, Elangovan L, Germain MJ, Lindberg JS, Sprague SM, Williams ME, Bishop CW. Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. Am J Kidney Dis. 2004 May; 43(5):877-90. PMID: 15112179.
    Citations: 41     Fields:    Translation:HumansCTClinical Trials
  43. Williams ME. Promise or peril? Impact of the Medicare drug benefit on the ESRD population. Adv Chronic Kidney Dis. 2004 Apr; 11(2):228-33. PMID: 15216496.
    Citations: 1     Fields:    Translation:Humans
  44. Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J, Porter C, Koch G. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004 Jan; 52(1):93-8. PMID: 14687321.
    Citations: 43     Fields:    Translation:HumansCTClinical Trials
  45. Bolton WK, Cattran DC, Williams ME, Adler SG, Appel GB, Cartwright K, Foiles PG, Freedman BI, Raskin P, Ratner RE, Spinowitz BS, Whittier FC, Wuerth JP. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol. 2004 Jan-Feb; 24(1):32-40. PMID: 14685005.
    Citations: 123     Fields:    Translation:HumansCTClinical Trials
  46. Williams ME. New therapies for advanced glycation end product nephrotoxicity: current challenges. Am J Kidney Dis. 2003 Mar; 41(3 Suppl 1):S42-7. PMID: 12612951.
    Citations: 6     Fields:    Translation:HumansAnimals
  47. Williams ME, Owens JE, Parker BE, Granata KP. A new approach to assessing function in elderly people. Trans Am Clin Climatol Assoc. 2003; 114:203-16; discussion 216-7. PMID: 12813921; PMCID: PMC2194506.
    Citations:    Fields:    Translation:Humans
  48. Williams ME, Chianchiano D. Medicare medical nutrition therapy: legislative process and product. J Ren Nutr. 2002 Jan; 12(1):1-7. PMID: 11823988.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Williams's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (206)
Co-Authors (5)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.